Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,131,096    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,069,946      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 8 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2006-07-03 4 AB $14.44 $21,660 D/D 1,500 29,381 2.81 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2006-08-01 4 AB $14.50 $21,750 D/D 1,500 30,881 2.81 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-03-02 4 AS $16.44 $24,723 D/D (1,500) 18,142 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-05-02 4 AS $16.36 $24,647 D/D (1,500) 15,142 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2009-06-12 4 B $14.52 $21,780 D/D 1,500 51,940 2.81 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2009-12-22 4 AS $18.83 $28,245 D/D (1,500) 53,940 0 -
NGSX Neurogesx Inc Director   –       •      –    2010-05-19 4 S $8.71 $13,065 D/D (1,500) 12,121 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-02-27 4 S $56.46 $84,683 D/D (1,500) 120,401 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-21 4 S $126.10 $189,157 I/I (1,500) 31,758 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-07-07 4 S $139.07 $208,600 I/I (1,500) 30,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-08-12 4 AS $134.72 $202,083 I/I (1,500) 28,758 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-04-05 4 OE $14.39 $21,585 D/D 1,500 393,721 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-04-06 4 OE $14.39 $21,585 D/D 1,500 395,221 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-07-23 4 OE $17.86 $26,790 D/D 1,500 286,790 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-07-23 4 AS $101.69 $152,535 D/D (1,500) 285,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-09-04 4 AS $98.16 $147,240 D/D (1,500) 285,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-09-04 4 OE $17.86 $26,790 D/D 1,500 286,790 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-10-03 4 AS $99.36 $149,040 D/D (1,500) 286,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-10-03 4 OE $17.86 $26,790 D/D 1,500 287,790 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-11-02 4 AS $97.88 $146,820 D/D (1,500) 288,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-11-02 4 OE $17.86 $26,790 D/D 1,500 289,790 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-12-28 4 AS $88.77 $133,155 D/D (1,500) 297,052 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-12-29 4 AS $88.18 $132,270 D/D (1,500) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-10-31 4 S $86.55 $129,825 D/D (1,500) 322,824 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-12-02 4 S $103.97 $155,967 D/D (1,500) 321,424 0 -
  850  Records found
  1   2   3   4   5   6   7   8  9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34      
  Page 8 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us